Pages

“Many people praise and acknowledge the healing power of plants, but few people actually take action to prevent their extension by planting and conserving them for future generations.” (Ernest Rukangira )

Friday, 17 October 2014

FW: From the SIDS International Conference to new Programmes launches, the 10YFP is picking up speed worldwide

+

10YFP Newsletter #7 - October 2014

FR | ES

From the SIDS International Conference to new Programmes launches, the 10YFP is picking up speed worldwide

SCP highlights

Case study
Mauritius, the sustainable island: how Mauritius is mainstreaming SCP in its development process 

Interview with UNEP Regional Director and Representative for Asia Pacific in International Innovation highlighting the role and importance of the 10YFP and its regional roadmap in Asia Pacific!

1-2 September: Capacity building workshop and consultation on Sustainable Buildings with 10YFP National Focal Points, Singapore.

11-12 Septeber: Agri-Food Taskforce meeting at the FAO Headquarters, Rome, Italy.

1 October: first MAC meeting for Sustainable Tourism programme.

13-14 October: Meeting of the Executive Committee of the Latin America and Caribbean Regional Council of Government Experts on SCP, Santiago, Chile.

SCP included as Goal 12 in the outcome document of the Open Working Group on the Sustainable Development Goals, 19 July 2014, subsequently conveyed to the UN General Assembly for the forthcoming negotiations on the post-2015 development agenda.

 

UPCOMING EVENTS

15-16 October: 3rd Board meeting of the 10YFP, Santiago, Chile.

21-23 October: South East Asia training workshop for 10YFP National Focal Points, Vientiane, Laos.

27 October: 1st 10YFP regional meeting for Eastern Europe, Geneva, Switzerland.

5 November: Official launch of the Sustainable Tourism Programme, World Responsible Tourism Day of the World Travel Market Conference, London, United Kingdom.

6-7 November: 1st meeting of the Consumer Information Programme, with co-leads and MAC members, Paris, France.

11 November: Official launch of the Sustainable Lifestyles and Education Programme at the World Conference on Education for Sustainable Development, Nagoya, Japan.

Key publications

10YFP Brochure
(Available in Chinese, English, French and Spanish)

Sustainability of Supply Chains and Sustainable Public Procurement: A Pre Study

Updated: 
Asia Pacific Regional Roadmap 

VISIT THE 10YFP WEBSITE!
www.unep.org/10YFP

SCP Side Event at the 3rd International Conference on Small Island Developing States 

Ministers of Environment and other high-level actors in Small Island Developing States (SIDS) stand united in calling for new, innovative and transformative means of implementation to promote the shift to sustainable consumption and production patterns. This was the main message at the side event "Small Islands: high stakes and increased opportunities for promoting sustainable consumption and production (SCP)", hosted by the Republic of Mauritius and co-hosted by UNEP at the Third International Conference on SIDS on 1 September, 2014, Apia, Samoa.

In the outcome document from the conference, member states have called for “support for SIDS efforts to develop and implement programmes under the 10YFP to advance SCP for SIDS,...” The side event focused on the announcement of an “SCP for SIDS Initiative within the 10YFP”, which will deliver concrete support to SIDS as they initiate or scale up existing SCP initiatives over the next 8 years. Panellists expressed their commitment to SCP in SIDS and highlighted the necessity of shifting to SCP patterns in crucial sectors such as tourism, waste and food.

10YFP Programmes Consultation and Upcoming Launches

A draft concept note of the Sustainable Lifestyles and Education (SLE) programme is currently available for on-line public consultation until 17 October. The concept note was developed following an expert meeting and an on-line survey in July that garnered 171 responses from all regions and helped identify their priorities on SLE. Any partner interested in joining the programme is welcome to express interest by 17 October. The launch of the SLE programme will take place on 11 November at the UNESCO Education for Sustainable Development Conference, in Nagoya, Japan.

A public consultation on the draft concept note of the Sustainable Buildings and Construction (SBC) programme was conducted in September and the programme received a number of written comments as well as verbal feedback during workshops held in Asia. The proposed work streams for the SBC programme are: to establish and promote enabling frameworks to implement SBC policies; to support and promote sustainable social housing; promote resource efficiency in building supply chain; reduce the climate impact of building sector; and knowledge sharing, outreach and awareness raising on SBC. Comments to the concept note are currently being integrated, and expressions of interest are being assessed to constitute the twenty-member Multi-stakeholder Advisory Committee (MAC) of the programme. The programme is expected to be launched by the end of 2014 or early 2015.

The first outline of the Sustainable Food Systems programme was developed at an expert session of the Agri-food SCP Taskforce on 11-12 September at FAO Headquarters in Rome, Italy. The results of an on-line survey on food systems in July that gathered 212 responses from various stakeholders were also presented. The survey indicated that food security and nutrition, climate change, food losses and waste, biodiversity and habitat loss, and water scarcity and efficiency were key issues of focus for the programme. The meeting resulted in a consensus among the experts on the vision, goal and three work streams of the future programme.

Finally, the official launch of the Sustainable Tourism programme will take place at the World Travel Market Conference on 5 November, London, United Kingdom. The programme will be led by the UN World Tourism Organization (UNWTO), and co-led by the Ministries of Tourism of Korea and Morocco, and the Ministry of Ecology and Sustainable Development of France. These lead organizations will benefit from guidance from a twenty-two member MAC. The four agreed work areas of the programme are: integrating sustainable consumption and production (SCP) patterns in tourism related policies and frameworks; collaboration among stakeholders for the improvement of the tourism sector´s SCP performance; fostering the application of guidelines, instruments and technical solutions to prevent and mitigate tourism impacts and to mainstream SCP patterns among tourism stakeholders; and enhancing sustainable tourism investment and financing.



3rd 10YFP Board Meeting hosted by Chilean Government

The third 10YFP Board meeting will take place in Santiago, Chile on 15-16 October. The Board will be updated on development and implementation of the 10YFP programmes. The status of SCP in Sustainable Development Goals (SDGs) will be covered, with a focus on the potential role of the 10YFP. In addition, a proposal for Global Benchmark Survey on National SCP Policies, to be conducted by the 10YFP Secretariat to review the development and implementation of current national SCP policies will be discussed. This meeting will also be an opportunity for a dialogue between the members of the Executive Committee of the LAC Regional Council of Government Experts on SCP, representatives of the Economic Commission for Latin America and the Caribbean (ECLAC) and the Board. 

The process of opening the 10YFP Trust Fund to calls for proposals will also be covered in the meeting. The guidance document for such calls for proposals has been finalized. The projects selected to receive Trust Fund support in the context of individual 10YFP programmes will respond to the SCP priorities and needs of developing countries and countries with economies in transition. The first call for proposals to support the 10YFP Sustainable Public Procurement Programme was launched on 14 October. It is expected that the Board will request a second call for proposals to be launched for the Consumer Information Programme during the last quarter of 2014.



Sustainable Public Procurement Programme Implementation Unfolding Worldwide

A new pre-study on Sustainability in Supply Chains and Sustainable Public Procurement, co-authored by UNEP and the Swedish Environmental Management Council, was launched through the working group on Greening Supply Chains of the 10YFP Programme on Sustainable Public Procurement (SPP). Further upcoming in-depth reports from working groups of the 10YFP SPP Programme include one US Environmental Protection Agency funded on incorporating Product-Service Systems into SPP, written with the Dutch Ministry for Infrastructure and the Environment, and another on Monitoring and Evaluating SPP Implementation, written with Ecoinstitut Barcelona, both set for publication in early 2015.

The Guardian on 25 June 2014 released an article on how government spending could save the world, highlighting SPP and the 10YFP Programme on SPP as an international programme, led by UNEP, KEITI, and ICLEI. The 10YFP SPP Programme was launched in April 2014 and is gaining increasing recognition around the world. As of 15 September, the Programme had 73 Partners from all regions and many different kinds of institutions, including private businesses, national governments, individual experts, intergovernmental organizations and NGOs.

Recently, the 10YFP SPP Programme made an appearance at EcoProcura, ICLEI’s bi-annual international meeting on SPP. At EcoProcura, the Multistakeholder Advisory Committee (MAC) gathered in person to discuss the programme’s projects and ongoing activities. Additionally, UNEP presented the programme to the entire EcoProcura audience at a plenary session and at the Market Lounge. Both presentations increased the visibility of the programme as well as expanded the programme’s network.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FW: Traditional Knowledge Bulletin

Traditional Knowledge Bulletin

Link to Traditional Knowledge Bulletin


This week in review … Eighth session of UNESCO Committee on Intangible Cultural Heritage opens in Baku

Posted: 05 Dec 2013 03:33 AM PST

8th session of the Committee for the Safeguarding of Intangible Heritage opens in Baku
UNESCO press release, 2 December 2013

BAKU, AZERBAIJAN: The eighth yearly meeting of the Intergovernmental Committee for the Safeguarding of Intangible Heritage, chaired by Abulfas Garayev, Azerbaijan's Minister of Culture and Tourism, opened in Baku in the presence of some 800 delegates from approximately 100 countries. From 2 to 7 December, the 24 members of the Committee in charge of implementing UNESCO's Convention for the Safeguarding of Intangible Cultural Heritage will take stock of achievements in promoting intangible cultural heritage ten years after the adoption of the Convention, which has been ratified by 157 States Parties. During the meeting, the Committee inscribed new elements in the List of Intangible Cultural Heritage in Need of Urgent Safeguarding including: Chovqan, a traditional Karabakh horse-riding game in the Republic of Azerbaijan; the Paach ceremony celebrated in Guatemala; Mongolian calligraphy; and the Empaako tradition of the Batooro, Banyoro, Batuku, Batagwenda and Banyabindi of western Uganda. In addition, 14 elements were inscribed on the Representative List of the Intangible Heritage of Humanity.

An exhibition from 28 October to 10 December 2013 on the railings of the UNESCO buildings in Paris, France, aims to illustrate the role that living heritage can play in sustainable development, and will be available to the public in digital form in the future. The examples taken from different parts of the world have attempted to show how the cultural practices, expressions and knowledge that form the intangible cultural heritage are important, among other things, for the respect of sustainable environment, food security, the support of community livelihoods, strengthening social cohesion and resolving disputes. Read the release … Further information on the meeting … Visit the meeting's website … Follow the meeting's live webcast …


This week in review … Slow Food and FAO launch "Quinoa in the Kitchen"

Posted: 05 Dec 2013 03:31 AM PST

Slow Food and FAO launch "Quinoa in the Kitchen"
FAO release, 3 December 2013

ROME, ITALY: The Slow Food movement and FAO officially launched the book, "Quinoa in the Kitchen," to continue to promote awareness about the super-food's potential, as the International Year of Quinoa 2013 draws to a close. The book gives an overview of quinoa's roots in the history and culture of the central Andean high plateau, geographically extending across the borders of Peru and Bolivia, which together account for the vast majority of quinoa production in the world. Since quinoa is still new to many beyond the Andes, the book includes a selection of quinoa recipes created by some of the world's top chefs. Read the release … Download the book [pdf] …


Meeting prep: IPBES-2

Posted: 05 Dec 2013 03:29 AM PST

Second Meeting of the Plenary of the Intergovernmental Platform on Biodiversity and Ecosystem Services
9-14 December 2013 (Antalya, Turkey)

The second meeting of the IPBES Plenary will consider, among several organizational, institutional and financial items, the initial work programme of the Platform 2014-2018 and its stakeholder engagement strategy, including with indigenous peoples and local communities. Among the meeting's information documents is the report from the expert workshop on indigenous and local knowledge systems to IPBES, held in Tokyo in June 2013, and initial elements for an approach towards principles and procedures for working with indigenous and local knowledge systems proposed for use by the IPBES. Visit the meeting's webpage, including links to working documents … Follow the meeting's coverage by IISD Reporting Services …


Meeting prep: CBD LAC workshop on TK

Posted: 05 Dec 2013 03:27 AM PST

Regional Capacity-building Workshop for Latin America and the Caribbean on Traditional Knowledge under the CBD
9-11 December 2013 (Cochabamba, Bolivia)

Organized by the Secretariats of the Convention on Biological Diversity (CBD) and the Amazon Cooperation Treaty Organization (ACTO), this workshop will provide an overview of the CBD, including its Strategic Plan for Biological Diversity 2011-2020 and the Aichi targets, and focus on issues related to: the participation of indigenous and local communities in the work of the Convention; CBD Articles 8(j) (traditional knowledge) and 10(c) (customary sustainable use) and current work in preparation for the twelfth meeting of the Conference of the Parties to the CBD; the interlinkages between biological and cultural diversity; and the dialogue among diverse knowledge systems: connecting traditional knowledge systems and science. Visit the meeting's webpage, including links to additional information material and tools for capacity building …


Resource: IDDRI policy brief on biodiversity and TK protection

Posted: 05 Dec 2013 03:25 AM PST

Biodiversity and Traditional Knowledge: How can they be protected?
Claudio Chiarolla, Renaud Lapeyre
IDDRI Policy Brief no 13/2013

This brief summarizes the proceedings of the international conference organized on 7 June 2013 in Paris, France, by the Fondation d'Entreprise Hermès and IDDRI, in collaboration with the Bibliothèque Nationale de France. Taking a multidisciplinary approach, the aim of the conference was to examine efforts to protect biocultural heritage and traditional knowledge (TK) associated with biodiversity. Its objective was to provide a critical assessment of the legal and economic tools that can be used to improve the potential contribution of biocultural diversity and TK to the livelihoods of local communities and to biodiversity conservation. It was indicated that conceptual models based on multidisciplinary approaches are the most appropriate to understand biodiversity values, particularly from a public good perspective. Overall, the need was stressed to undertake further work on the factors that contribute to the erosion of biocultural diversity; and focus attention on social movements and indigenous peoples' claims, since in most cases ILCs have developed innovative tools, such as farmers' initiatives based  on agro-ecology and dynamic management of biodiversity in the field. ILCs' fight for the recognition of their land rights is thus crucially important, while recognizing that such communities' knowledge is heavily affected by climate change in terms of species' disappearance and by the lack of access to natural resources. Finally, promoting policies to ensure democratic stability and economic development relies on our capacity to preserve and sustainably use biodiversity. Read the brief …


 

 

Thursday, 16 October 2014

Medicinal Crops of Africa


Reprinted from: Issues in new crops and new uses. 2007. J. Janick and A. Whipkey (eds.). ASHS Press, Alexandria, VA.
Medicinal Crops of Africa
James E. Simon*, Adolfina R. Koroch, Dan Acquaye, Elton Jefthas, Rodolfo Juliani, and Ramu Govindasamy
The great biodiversity in the tropical forests, savannahs, and velds and unique environments of sub-Sahara Africa has provided indigenous cultures with a diverse range of plants and as a consequence a wealth of traditional knowledge about the use of the plants for medicinal purposes. Given that Africa includes over 50 countries, 800 languages, 3,000 dialects; it is a veritable treasure of genetic resources including medicinal plants. While the medicinal plant trade continues to grow globally, exports from Africa contribute little to the overall trade in natural products and generally only revolve around plant species of international interest that are indigenous to Africa. Africa is only a minor player in the global natural products market. We identified several key challenges facing the natural products sector in this region. These include the presently limited value-addition occurring within region and as a consequence exports tend to be bulk raw materials; local markets generally largely selling unprocessed/semi-processed plant materials; the industry is large but informal and diffuse and there is limited financial resources to support research and infrastructure for both the processor and a distinct but equally important issue in the lack of financial credit available in general to the farmer in much of this region for production investments; lack of private sector investment in processing and packaging facilities; and serious issues in parts of this region surround common property resource issues (ownership and rights to land tenure; threat of over-harvesting, etc.). In addition, there is limited technical support is available to growers, collectors, & post-harvest firms, limited expertise on appropriate germplasm and seed availability, inadequate and/or lack of processing equipment. This has resulted in a lack of or inadequate quality control and lack of product standardization. There is a very limited knowledge of foreign market demand, few market/business contacts and the perception that there is difficulty in protecting their intellectual property.
The objective of this paper is to present an overview to some of the leading African medicinal plants in sub-Sahara Africa that are in the international trade, plus an introduction to a number of lesser-known promising medicinal plants (Table 1).
Cryptolepis sanguinolenta
Cryptolepis sanguinolenta (Lindl.) Schltr. (Periplocaceae) is a climbing shrub with blood-red colored juice in the cut stem (Paulo and Houghton 2003). The leaves are glabrous, oblong-elliptic or ovalate, shortly acuminate apex, rounded, sometimes acutely cuneate base. The flowers are greenish-yellow, the fruit is a follicle, linear 17–31 cm long, and the seeds are 10–12 mm long with a tuft of silky hairs at the end. The plant grows in the rainforest and deciduous forest belt (Iwu 1993) and is found in secondary forest from Nigeria, Ghana to Senegal (Dokosi 1998).
In local traditional medicine, the macerated roots are used as hypotensive and antipyrectic (colic) agents and as a tonic for rheumatism and against gastrointestinal problems (Oliver-Bever 1986). In Ghana, the root-bark is used in folk medicine to increase virility (Dokosi 1998). Root decoction has been used by traditional healers for the treatment of several fevers (malaria, infections of stomach) and the leaves as an antimalarial and for the cicatrizing of wounds (Oliver-Bever 1986; Iwu 1993; Iwu et al. 1999; Neuwinger 2000).
Roots contain a quinoline-derived indole alkaloid, cryptolepine, reported to have a marked hypothermic effect, as well as inducing prolonged vasodilatation, causing marked and durable hypotension. Cryptolepine
*This work was conducted as part of our Partnership for Food and Industry in Natural Products (PFID/NP) project with funds from the Office of Economic Growth, Agriculture and Trade (EGAT/AG) of the USAID (Leader Contract Award No. AEG-A-00-04-00012-00) and an Associate Award (Associate Cooperative Agreement No. 690-A-00-06-00126-00) from the USAID-Regional Center for Southern Africa. We thank Carol Wilson and Jerry Brown, USAID Cognizant Technical Officers for each of the PFID/NP for their active involvement, support and encouragement. This work originally began in 1999, as part of our ASNAPP program with funding from the USAID (Contract Award No. HFM-O-00-01-00116). As all our African research is implemented by the ASNAPP network (www.asnapp.org) we thank the ASNAPP organization as well as the New Jersey Agricultural Experiment Station, Rutgers University who each provided support for this work. Lastly, we give particular thanks and recognition to those African small farmers, scientists, researchers and traders and healers who have always opened their doors to us, and for whom this article is dedicated to generate awareness and interest in African natural products.
323
Botanicals and Medicinals
containing plants have been use by local peoples also as a natural dye. It has low toxicity and the aqueous extract of the root has antimicrobial activity against three urogenital pathogens (Neisseria gonrrhoeae, E. coli, and Candida albicans), but not against Pseudomonas aeruginosa (Oliver-Bever 1986).
Cryptolepine is the major alkaloid which occurs at a yield of 0.52% w/w in the roots, 0.48% in stems, 1.03% in leaves (Iwu 1993). Cryptolepine is a rare example of a natural product whose synthesis (1906) has been reported before its isolation (23 years later) (Bierer et al. 1998a).
Aqueous extracts of C. sanguinolenta are of interest today because of their antimicrobial (Paulo et al. 1994a,b; Silva et al. 1996; Sawer et al. 2005), antimycobacterial (Gibbons et al. 2003), antihyperglycemic (Bierer et al. 1998a,b; Luo et al. 1998), antimalarial (Tona et al. 1999; Paulo et al. 2000; Wright et al. 2001, 2005; Willcox and Bodeker 2004; Ansah et al. 2005), antiamoebial (Tona et al. 1998) and anticancer potential (Ansah and Gooderham 2002), supporting the plants multiple traditional uses in traditional medicine. Of particular interest is its application as a new potential antimalarial whose mode of action is distinct from that of chlorine and artemisinin-derived drugs. Preliminary clinical trials have shown promising results as a remedy against malaria in Ghana.
Cinnamomum camphora
Cinnamomum camphora (L.) J. Presl (camphor tree, Lauraceae) is native to China, Taiwan and Japan. Later introduced into several other regions, the tree has become naturalized in parts of Southern Africa (Van Wyk et al. 1997), Australia, Madagascar, and the United States.
Camphor tree is locally known under a variety of names including ravintsara (Madagascar); kanferboom (Afrikaans); and uroselina (Zulu). It is a dense broadleaved evergreen that can reach 26 m in height with shiny foliage, made up of alternate oval leaves. Each leaf has three distinct yellowish veins. The outer margins of the leaves tend to be somewhat wavy and turn upward. The new foliage starts out a rusty burgundy color, but the leaves soon turn dark green on the upper sides and paler green underneath. New branches emerging from the shallowly fissured grayish brown trunk are smooth and green. Inconspicuous tiny cream colored flowers are followed by small round purple berries (Coates Palgrave et al. 2000). Most noticibly, the camphor tree can be readily identified by the strong camphor aroma coming from all parts pf the plant (Van Wyk et al. 1997).
Camphor is widely planted as a shade tree or windbreak. In China and Japan, it is grown commercially for its aromatic volatile oil used in traditional medicine. Natural camphor is distilled from the wood of the camphor tree (Van Wyk et al. 1997). Camphor oil has a strong penetrating fragrance, a pungent bitter flavor, and feels

Issues in New Crops and New Uses
cool on the skin like menthol, though it also has irritating qualities as well as a numbing effect.
In traditional medicine camphor is used to treat coughs, fever due to flu (bark tea), malarial fever (leaf extract), malaria (leaf infusion is inhaled), and as an antiseptic, counter-irritant, stimulant, carminative, and analeptic. In Europe, camphor has mainly been used for the treatment of colds and inflammation, but also to treat heart conditions, infections, pneumonia (as antibacterial), and diarrhea. Infusion of dried leaves is used as a Zulu ritual emetic (Grieve 1967; Van Wyk et al. 1997; Neuwinger 2000). In modern medicine, camphor is used externally as topical antiseptic agent and antipruritic and internally as a stimulant and carminative (Merck 1989).
Camphor wood is prized for its attractive red and yellow striping, amenability to woodworking, and insect repelling properties. It is light to medium in weight and soft to medium in hardness. Wood from the camphor tree is not especially strong, but it takes polishing well. The wood is commonly used in making chests, closets, coffins, instruments, and sculptures. Camphor veneer is used in fine cabinetry. Oil of camphor is also used in perfumes, as an insect repellant, and in aromatherapy. The essential oil is produced by steam distillation of the wood, root stumps, branches, leaves, stems, and even fruit, then rectified under vacuum and filtered pressed to produce three fractions, known as white, brown, and yellow camphor. Wood from the tree is the principal source of natural camphor. Extracted oil from the leaves, stems and fruit also yields hydrocyanic acid as well as safrole, borneol, heliotropin, terpineol, and vanillin (Williamson and Evans 1988). Other compounds isolated from the plant include five lignins, two of which are secoisolariciresinol dimethyl ether and kusunokiol (Hutchings et al. 1996).
M
ondia whitei
Mondia whitei (Hook. F.) Skeels (Apocynaceae) is also known as mondia, or White’s ginger. Mondia is a vigorous climber (3–6 m high) with attractive heart-shape leaves and a vanilla aroma. The flowers are arranged in panicles, yellow and reddish-purple. It is widely distributed in tropical Africa from Guinea through Cameroon to East Africa.
Mondia has been a popular medicinal in several African countries used by traditional medicine traders for a long time (Cunningham 1993). Extensively used for medicinal properties, in traditional medicine, the dried roots are chewed and the sap is swallowed for appetite stimulation, stomach pain, indigestion and body pain, gastrointestinal disorders, gonorrhea, post-partum bleeding, pediatric asthma, and to stop vomiting (Kokwaro 1976; Neuwinger 2000). In all countries and across all tribes, mondia finds itself also used as an aphrodisiac. In Cameroon, the fresh root bark is used to increase the libido, in Ghana to increase sperm production. Watcho et al. (2001, 2004, 2005, 2006) have reported that chronic administration of M. whitei root bark extract, showed androgenic properties in male rats.
Chemical studies of mondia from root extracts show both an unknown alkaloid and 2-hydroxy-4-methoxybenzaldehyde (Kubo and Kinst-Hori 1999) reported to exhibit tyrosinase activity (tyrosinase activity is involved in the melanin synthesis) (Nihei et al. 2004). A chlorinated coumarinolignan (5-chlopropacin) has been found in the roots of M. whitei (Patnam et al. 2005).
Due to the plants medicinal uses, recent interest has begun to explore the cultivation rather than only the collection of this plant. Little has been reported on the small-scale field cultivation of this plant, but it appears to be easily vegetatively propagated, grows well and easily under a range of soil and environmental conditions (pers. observ.). A successful in vitro propagation method was recently developed for several medicinal plants including mondia (Afolayan and Adebola 2004).
H
oodia spp.
Hoodia currorii (Hook.) Decne. (Asclepiadaceae) is locally known as ghaap or “! khobab”. Hoodia is a succulent plant that grows in the Kalahari Desert region of South Africa, including Namibia, Angola, and Botswana. Flowers smell strongly of decaying meat, and are pollinated by flies. It is known as the “stinky” plant with “miraculous” properties (Van Wyk and Gericke 2000). Several Hoodia spp. are eaten fresh as raw food. They are used as appetite and thirst suppressants to treat indigestion, hypertension, diabetes, and stomaches (Van Wyk and Gericke 2000). Hoodia spp. are used as a convenient emergency food and moisture source in harsh arid environments. As food, the spines are scraped off the succulent stems and the stems are eaten like
325
Botanicals and Medicinals
cucumber. The taste is bitter and texture mucilaginous. It is preferable to eat stems after a rain, when moisture content is highest. Sometimes they are soaked in water before being eaten. Hoodia has become recently very popular as a diet suppressant aid and can be found in the supermarkets and shops all across the US.
Other Hoodia species also are reported to have similar applications. For instance, H. gordonii (bitterghapp) is eaten fresh, and is used as an appetite-suppressant by shepherds (Van Wyk and Gericke 2000). Recently, it was shown that H. gordonii extract was able to induce weight loss or control appetite in mammals, and these extracts were dominated by chlorogenic acid and a sterol glycoside such as P57 (Holt 2006). This is the principal species or source of the Hoodia that is reported and listed as being traded, yet the lack of quality control and the ease of adulteration using other species and plant extracts has become a real concern. Plant extracts have been reported to control obesity and in the treatment of related health conditions including syndrome x (Holt 2006). Moreover, it has been cited as a meal replacement (Shatkina et al. 2006). H. flava (yellow flower ghaap) is eaten fresh, and as appetite–thirst suppressant. H. officinalis has been used to treat pulmonary tuberculosis and hemorrhoids. H. pilifera is also edible, suppresses thirst and hunger and is used in brandy tinctures, as a stomachic, and to treat hemorrhoids and pulmonary tuberculosis (Van Wyk and Gericke 2000). In African traditional medicine H. currori is also used to treat diabetes (Neuwinger 2000).
The Council for Scientific and Industrial Research (CSIR) in South Africa investigated the plant’s effect and demonstrated in animal studies that an extract from the plant was highly effective in reducing weight. In 1997, the CSIR approached a company (Phytopharm, UK) to collaborate in the development of a prescription drug with the active ingredient P57. At one point Phytopharm had signed a licensing agreement with Pfizer who would have marketed P57 in the rest of the world (Habeck 2002). Maintaining intellectual property rights and providing benefits to the indigenous peoples who provided the traditional knowledge that led to the scientific discovery is a rather complex and entangled issue. Other issues facing the Hoodia industry and regions where it is cultivated are; difficulty in meeting consumer demand due to slow growth of this species; adulteration of commercial products with other Hoodia and non-Hoodia species; and using sustainable cultivation and harvesting practices.
Voacanga africana
Voacanga africana (Apocynaceae) is an understory forest shrub reaching 6 m high with low widely spreading crown, distributed mainly in West Africa from Senegal to the Sudan and south to Angola (Iwu 1993). Known locally kokiyar (in Hausa), pete-pete (in Igbo); kirongasi (in Swahili); or ako-dodo (in Yoruba) the plant is a popular medicinal. The leaves are opposite obovate and acuminate, dark green and glossy and usually stalkless. Flowers are white borne in axiliary or terminal loosely branch glabrous inflorescence. Spherical, mottled green fruit occurs mainly in pairs, with seeds wrapped in yellow pulp.
Voacanga has a broad range traditional medicinal uses. In Cote d’ Ivore this plant is used against leprosy, diarrhea, generalized edema, convulsions in children, madness (Tan et al. 2000), as a diuretic, and infant tonic (Iwu 1993). A decoction of the stem bark and root is used in the treatment of mental disorders and the latex is applied to carious teeth. The decoction of the bark is considered an analgesic and is added to embrocating mixtures used as pastes during fracture repair. Bark and root decoctions are also used to treat cardiac spasms. The fruit decoction is used as a disinfectant, and the leaf decoctions to treat asthma to children (Neuwinger 2000). In southeastern Nigeria the plant is featured in many healing rituals (Iwu 1993), including some to induce hallucinations and trances in religious rituals. In Congolese traditional medicine preparations of extracts containing V. africana are used as anti-amoebial. Intestinal amoebiasis is one of the current diseases in tropical regions causing diarrhea. It has been reported that V. africana has active activity against Entamoeba histolytica in vitro (Tona et al. 1998).
The anti-ulcer properties and the gastric protective effect of the aqueous bark extract of V. africana against HCl:ethanol solution was demonstrated (Tan et al. 1997, 2000). Finally, Voacanga alkaloids have been shown to have cardiotonic, sympatholytic, and hypotensive properties (Oliver-Bever 1986). Analysis of root and bark extracts of V. africana showed the presence of the alkaloids including voacamine, voacangine, and vobasine (Oliver-Bever 1986). Other compounds found in the plant include voacristine, voacamidine, and voacarine. Voaphylline, vobtusine, and voalfolidine occur in the leaves and tabersonine is a constituent of the seeds (Rolland et al. 1976; Iwu 1993). The alkaloid ibogaime, is a powerful hallucinogen also found in voacanga (Kombian et al.
326
Issues in New Crops and New Uses
1997), supporting its use in ritual in traditional medicine. Ibogaine affects the peripheral and central nervous system, and is being examined for use in the treatment of withdrawal symptoms and cravings in drug addicts (Glick et al. 1992). Many other natural products have been reported including flavonoids, tannins, steroids, and terpenes in the roots and bark (Tona et al. 1998). A difficulty in quality control of this product is the lack of commercially available standards of the specific alkaloids.
Aframamomum meleguetata
Aframomum melegueta K. Schum, (Zingiberaceae) is a spice native to tropical West Africa (Iwu 1993). Locally it is known as melegueta pepper, fomwisa, wisa, apokuo, efom wisa, obro, (Yoruba), chitta (Hausa), and also as grains of paradise, guinea pepper, and alligator pepper. This aromatic plant is cultivated for its edible spicy fruit.
Grains of paradise is a tufted, leafy, herbaceous perennial. It has a short, scaly rhizome with a surface root system. The stem is 0.9 to 1.2 m high, covered by leaf sheaths up to 2 m in length. Leaves are alternate and sessile continuing into a sheath of the stem. The large pink flowers are trumpet shaped with a single stamen. The ovoid fruit tapers to a point, surrounded by a permanent calyx. The matured fruit is red in color and contains a white pulp that surrounds 1,200 to 2,000 seeds. Flowering begins in September and fruiting in December. The seeds are small (0.4 to 0.5 cm long), aromatic with grainy testa and white kernel. The seeds have a very hot taste (Iwu 1993; Dokosi 1998).
In the 13th century, traders from West Africa carried the spice across the desert to sell in Tripoli and then Italy. The Italians called it “grains of paradise” because of the high value of the product, and the secrecy of the country of its origin. Europe acquired a taste for the spice as a substitute for real pepper (Enti 1998). In England during the reign of Queen Elizabeth I, many foodstuffs and drinks were flavored with grains of paradise along with other spices such as cinnamon and ginger. While its popularity in Europe declined over time, its use in West and North Africa continues. In North Africa, the extract of the pepper, mixed with other ingredients like butter, honey, peanuts, and almonds, was used in after-dinner coffee. The spice is also used to flavor rum and brandy and beer. In Ghana, the seeds are widely used in spicing meat, sauces, and soups and mixed with other herbs for the treatment of body pains and rheumatism.
The genus has been extensively used in popular medicine in West and Central Africa. Leaves are used internally in treatment of measles and externally for leprosy, fresh fruit is used as an aphrodisiac, and the root decoction is taken by nursing mothers to control lactation and postpartum hemorrhage (Iwu 1993). Traditionally, the seeds are chewed to cure dysentery, as a sedative against toothache, to guard against rheumatism and migraine, and to cure fever. The rhizomes are used in the treatment of dysentery and diarrhea (Dokosi 1998). The seed is ground into a soft paste that has exhibited antibiotic properties (Enti 1998). The essential oil of Aframomum has exhibited activity against gram positive and gram negative bacteria as well as Candida albicans. The essential oil appears to be more active against gram-positive bacteria than gram-negative types, and the essential oil in a water soluble cream showed higher anti-microbial activity than the oil based cream. Moreover, seed extracts have shown strong termite antifeedant activity (Escoubas et al. 1995).
Chemical analysis of the seed have shown that hexanic and methanolic extracts are rich in (6)-paradols, (6)-gingerols and (6)-shogaols (Ghana Herbal Pharmacopoeia 1992; Escoubas et al. 1995; Juliani et al. 2007). The acetone extract of Ghanain grains of paradise contains hydroxyphenylalkanones (6)-paradole, (7)-paradole, and (6)-shoagole (Tackie et al. 1975).
A
spalathus linearis
Aspalathus linearis (N.L. Burm.) R. Dahlgr. (Fabaceae) is known locally as rooibos tea, African red tea, red bush, or mountain tea. Rooibos is a shrub of up to 2 m high, with bright green needle shaped leaves which become reddish-brown after processing. The flowers are small and yellow (Van Wyk and Gericke 2000). The genus Aspalathus comprises about 278 species and is endemic to South Africa. A. linearis present a high degree of polymorphism, in terms of morphological and ecological characters and also in its chemical (phenolic) constituents (Van Heerden et al. 2003).
The plants are harvested with sickles and tied into bundles. Then they are chopped in small segments, moistened, and left in heaps to “ferment” for several hours until a sweet smell develops. The green leaves turn
327
Botanicals and Medicinals
a characteristic red after fermentation (Van Heerden et al. 2003).
Rooibos tea contains no colors, additives, or preservatives, making it a natural beverage (Dos et al. 2005). Rooibos is a traditional beverage of the Khoi-descended people from the ClanWilliam region in the Cape (South Africa). Traditionally the leaves and twigs are used as a milk substitute for babies with colic, as antispasmodic, to block the nose (root pulp is put into the nose), and as an emetic. Also, Rooibos has been traditionally used for years to help with insomnia, disturbed sleeping patterns, and headaches. Rooibos tea contains no caffeine (chemical analysis conducted in our lab, data not presented) and has a relaxing effect on the central nervous system. Moreover, rooibos makes a great thirst-quencher and sports and endurance drink because of its abundant mineral content of iron, potassium, zinc, manganese, and sodium (Van Wyk et al. 1997; Neuwinger 2000; Van Wyk and Gerike 2000).
Over the last decade rooibos tea has gained popularity on international markets, largely because it is a versatile, caffeine-free tea with unique taste (Wilson 2005). Rooibos tea has proven antioxidant activity (Inanami et al. 1995; Joubert et al. 2004, 2005), is hepatoprotective (Ulicna et al. 2003), and suppresses skin tumor formation (Marnewick et al. 2000, 2005; Standley et al. 2001). In addition, rooibos is used as an ingredient in cosmetics, in diet products, as a flavoring agent in baking and cooking, and even as a milk substitute for infants who are prone to colic (Van Wyk and Gericke 2000).
The beneficial properties of rooibos teas are mainly attributed to low tannins, high mineral content, and the presence of the unique flavonoids such as aspalatin and nothofagin among others (Joubert 1996; VonGadow et al. 1997). While rooibos is considered a new crop it has a long history of export from South Africa to Europe. Value-added waste products remaining after the fermented tea is prepared may provide products for the cosmetic and personal heath care industries. Products such as shampoos, soaps, and more can be made with rooibos extracts to utilize the rich red natural pigments and the antioxidant properties of this unique South African product.
H
arpagophytum procumbens
Harpagophytum procumbens DC (Burch.) DC. ex Meisn. (Pedaliaceae) is also known as devil’s claw or harpago. It is a native South African herb, mostly known from the Namibian deserts (Hachfeld 2003). A perennial plant with annual stems spreading from a central tap root, its leaves are grayish-green, flowers are tubular either yellow and violet or violet. The characteristic fruits have numerous long arms with sharp, hooked thorns. The common names are derived from the claw-like fruit (Van Wyk et al. 1997; Van Wyk and Gericke 2000). This clinging fruit may cause injury when attached to the foot or hoof of an animal, while it also acts as a method of seed dispersal. Seed germination peaks in the rainy season, between November and March. During this time, the taproot develops and can grow up to 2 m deep. To be able to survive the long dry and severe dry periods, the plant forms water-storing secondary roots branching off from the primary taproot. The secondary roots are the plant parts used for medicinal purposes (Van Wyk et al. 1997).
Harpago has been used for centuries by Africans to treat fever, indigestion, malaria, allergies, rheumatism, and arthritis. In Europe, the root extract is recommended for arthritis, diabetes, allergies, and senility, and is widely utilized as a digestive aid and appetite stimulant (Iwu 1993; Neuwinger 2000). Harpago has been widely used in European herbal tea formulations, and in recent years, many health food marketing centers carry formulations containing the harpago extracts or root powders. The British and German Herbal Pharmacopoeias recognize harpago as possessing analgesic, sedative, and diuretic properties (Van Wyk et al. 1997; Van Wyk and Gericke 2000).
A clinical study carried out in Germany using root extracts, showed anti-inflammatory activity, comparable in many respects to the well-known anti-arthritic drug, phenylbutazone. In Europe a home remedy containing secondary roots is used for lack of appetite, dyspeptic complaints, and in supportive therapy for degenerative disorders of the locomotor system (Poukens-Renwart et al. 1996). Analgesic effects of secondary roots of harpago were also observed along with reductions in abnormally high cholesterol and uric-acid blood levels. Harpago is reported to help with joint pain while improving vitality in the joints. Current use in the western world has focused on its application to painful conditions of the muscular-skeletal system and digestive problems. It is an active ingredient found in some prescriptions for arthritis, rheumatic complaints, and for low back pain, especially associated with spondylosis, lumbago, sciatica, fibrositis, neuralgia, and polymyalgia. A double blind
328
Issues in New Crops and New Uses
placebo controlled clinical study with devil’s claw in tablet form was carried out on 118 patients who suffered with acute low back pain. After a six-week study, a greater number of patients on the Harpagophytum treatment became pain-free compared to the placebo group (Chrubasik et al. 1996). In rats, crude methanolic extracts of H. procumbens showed a significant dose-dependent, protective action towards hyperkinetic ventricular arrhythmias (Costa et al. 1985). Swiss Pharmacopoeia and European Pharmacopoeia recommended a minimum suitable level of 1.2% harpagoside content in the secondary roots (Poukens-Renwart et al. 1996).
The main active ingredients in harpago include harpagoside and β-sitosterol, which possess anti-inflammatory properties and create support for joint, ligament, and tendon problems. Of the principal constituents, the iridoid glycosides have been investigated, focusing in particular on the anti-inflammatory effects (Van Wyk et al. 1997; Van Wyk and Gericke 2000).
As with many other wild-harvested medicinal plants, the demand for devils claw has grown to the extent that native populations are now becoming scarcer and face potential threat of depletion (Hachfeld 2003). The threats to harpago and to the livelihoods of the people who are its principal harvesters are clearly linked to the nature of a trade dominated by unsustainable harvesting practices. Traditionally, the plants are harvested from the wild, while now there is some cultivation in southern Africa, largely in the Republic of South Africa (Cunningham 1993).
P
runus africana
Prunus africana Hook. f. (Rosacea) Kalkm. (syn. Pygeum africanum Hook) is commonly known as pygeum, bitter almond, red stinkwood, bitteramandel, rooistinkhout, and nuwehout. It is an evergreen tree that can reach 24 m with a trunk diameter >1 m. The bark is dark and rugged, the branches are brown and corky and the twigs knobby. The foliage is composed of shiny simple dark green leaves, arranged alternately, and have an aroma of almonds when crushed. The leaf stalks are often pink or red. White flowers are arranged in clusters (Palmer and Pitman 1972; Van Wyk et al. 1997). Prunus or pygeum are found mainly in the forests along the mistbelt regions of South Africa and it occurs further north into tropical Africa (Van Wyk et al. 1997). Its range extends into Eastern Africa (e.g. Kenya) as well as Western/Central Africa (e.g. Cameroon) and Madagascar.
Active principles come from the red or dark brown bark of the trees which has a weak aroma of hydrocyanic acid. The bark is extracted with an organic solvent, yielding a lipid and sterol extract. The active ingredients are phytosterols (free and conjugated beta-sitosterol, campesterol); tripterpenoid esters; pentacyclic acids (ursolic, oleanolic, crateaegolic, epimaslinic); and aliphatic alcohols (such as n-tetracosanol and n-docosaonol) and their ferulic acid esters. Bark decoctions are traditionally used in Zulu medicine, while lipid and phytosterol extracts are most commonly used in Europe (Van Wyk et al. 1997).
Traditionally, leaves of P. africana are employed as an inhalant for fever, to improve appetite, to treat chest and stomach pain, gonorrhea, inflammations, kidney diseases, urinary tract complains, and in Europe it become popular for the treatment of benign prostate hypertrophy (Kokwaro 1976; Van Wyk et al. 1997; Neuwinger 2000 ).
Pharmacological studies show antiedema activity, increase in bladder elasticity, and stimulation of prostatic secretion. This medicinal extract is nontoxic and lowers the plasma concentrations of LH and testosterone; no androgenic and estrogenic action detected. Clinical trials have shown that the extract provides significant impact on nocturnal pollakiuria and other symptoms of benign prostrate hypertrophy. It is similar to or comparable to saw palmetto, Serenoa repens fruit extracts.
Conclusions
Africa is a continent rich in medicinal plants and a treasure of biological diversity. The richness in the myriad of cultures and traditions integrally link their use of plants within their communities. As we continue to search for new plant-based therapies and products to improve health and nutrition, there is much to be learned scientifically from the traditional healers and indigenous peoples that use and treasure these medicinal plants. The ability to develop African medicinals in a manner that both leads to increased science, trade and respect of African traditional applications while doing so in a manner that economically benefits Africans and in an environmentally sustainable manner is the challenge now facing the awakening of African medicinals into the global market.
329
Botanicals and Medicinals
R
eferences
Afolayan A.J. and P.O. Adebola. 2004. In vitro propagation: A biotechnological tool capable of solving the problem of medicinal plants decimation in South Africa. African J. Biotechnol. 3:683–687.
Ansah, C. and N.J. Gooderham. 2002. The popular herbal antimalarial, extract of Cryptolepis sanguinolenta, is potently cytotoxic. Toxicol. Sci. 70:245–251.
Ansah, C., A. Khan, and N.J. Gooderham. 2005. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Toxicology 208:141–147.
Bierer, D.E., L.G. Dubenko, P.S. Zhang, Q. Lu, P.A. Imbach, A.W. Garofalo, P.W. Phuan, D.M. Fort, J. Litvak, R.E. Gerber, B. Sloan, J. Luo, R. Cooper, and G.M. Reaven. 1998b. Antihyperglycemic activities of cryptolepine analogues: An ethnobotanical lead structure isolated from Cryptolepis sanguinolenta. J. Med. Chem. 41:2754–2764.
Bierer, D.E., D.M. Fort, C.D. Mendez, J. Luo, P.A. Imbach, L.G. Dubenko, S.D. Jolad, R.E. Gerber, J. Litvak, Q. Lu, P.S. Zhang, M.J. Reed, N. Waldeck, R.C. Bruening, B.K. Noamesi, R.F. Hector, T.J. Carlson, and S.R. King. 1998a. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: Its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities. J. Med. Chem. 41:894–901.
Chrubasik, S., C.H. Zimpfer, U. Schutt, and R. Ziegler. 1996. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine 3:1–10.
Coates Palgrave, K., P. Coates Palgrave, and M. Coates Palgrave. 2000. Everyone’s guide to trees of South Africa. 4th ed. Struik Publ.
Costa de Pasquale, R., G. Busa, C. Circosta, L. Iauk, S. Ragusa, P. Ficarra, and F. Occhiuto. 1985. A drug used in traditional medicine: Harpagophytum procumbens DC. III. Effects on hyperkinetic ventricular arrhythmias by reperfusion. J. Ethnopharmacol. 13:193–199.
Cunningham, A.B. 1993. African medicinal plants. Setting priorities at the interface between conservation and primary heathcare. Plant and People Initiative. Unesco, France.
Dokosi, O.B. 1998. Herbs of Ghana. Ghana Universities Press, Accra.
Dos A, Z. Ayhan, and S. Gulum. 2005. Effects of different factors on sensory attributes, overall acceptance and preference of rooibos (Aspalathus linearis) tea. J. Sens. Stud. 20:228–242.
Enti, AA. 1998. The rejuvenating plants of tropical Africa. A.K. Andoh (ed.), FLS, North Scale Institute, San Francisco.
Escoubas, P., L. Lajide, and J. Mizutani. 1995. Termite antifeedant activity in Aframomum melegueta. Phytochemistry 40:1097–1099.
Ghana Herbal Pharmacopoeia. 1992. The Advent Press, PO Box 0102, Osu, Accra.
Gibbons, S., F. Fallah, and C.W. Wright. 2003. Cryptolepine hydrochloride: A potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta. Phytother. Res. 17:434–436.
Glick, S.D., C.A. Gallgher, L.B. Hough, K.L. Rossman, and I.M. Maisonneuve. 1992. Differential-effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine. Brain Res. 588:173–176.
Grieve, M. 1967. A modern herbal. Hafner, London.
Habeck M. 2002. A succulent cure to end obesity. Drug Discov. Today 7:280–281.
Hachfeld B. 2003. Ecology and utilisation of Harpagophytum procumbens (Devil’s Claw) in Southern Africa. Plant Species Conservation Monogr. 2. Federal Agency for Nature Conservation, Bonn, Germany.
Holt, S. 2006. Herbal compositions containing Hoodia. US Pat. 2006159773.
Hutching, A., A.H. Scott, G. Lewis, and A.B. Cunningham. 1996. Zulu medicinal plants: An inventory. Univ. Natal Press, Scottsville, South Africa.
Inanami, O., T. Asanuma, N. Inukai, T. Jin, S. Shimokawa, N. Kasai, M. Nakano, F. Sato, and M. Kuwabara. 1995. The suppression of age-related accumulation of lipid peroxides in rat-brain by administration of Rooibos Tea (Aspalathus-Linearis). Neurosci. Lett. 96:85–88.
Iwu, M., M., A.R. Duncan, and C.O. Okunji. 1999. New antimicrobials of plant origin. p. 457–462. In: J. Janick (ed.), Perspectives on new crops and new uses. ASHS Press, Alexandria, VA.
Iwu, M.M. 1993. Handbook of African medicinal plants. CRC Press, Florida. p. 257.
Joubert, E., P. Winterton, T.J. Britz, and D. Ferreira. 2004. Superoxide anion and alpha, alpha-diphenyl-beta-
330
Issues in New Crops and New Uses
picrylhydrazyl radical scavenging capacity of rooibos (Aspalathus linearis) aqueous extracts, crude phenolic fractions, tannin and flavonoids. Food Res. Int. 37:133–138.
Joubert, E., P. Winterton, T.J. Britz, and W.C.A. Gelderblom. 2005. Antioxidant and pro-oxidant activities of aqueous extracts and crude polyphenolic fractions of rooibos (Aspalathus linearis). J. Agr. Food Chem. 53:10260–10267.
Joubert, E. 1996. HPLC quantification of the dihydrochalcones, aspalathin and nothofagin in rooibos tea (Aspalathus linearis) as affected by processing. Food Chem. 55:403–411.
Juliani, H.R., C. Welch, J. Asante-Dartey, M. Wang, and J.E. Simon. 2007. Chemistry, quality and functional properties of grains of paradise (Aframomum melegueta), a rediscovered spice. In: C.T., Y. Shao and J.E. Simon (eds.), Dietary supplements. Am. Chem. Soc. Symp. Ser. American Chemical Society, Washington, D.C. USA (in press).
Kokwaro, J.O. 1976. Medicinal plants of East Africa. Kenya Literature Bureau, Nairobi.
Kombian, S.B., T.M. Saleh, N.I.Y. Fiagbe, X.H. Chen, J.J. Akabutu, J.K. Buolamwini, and Q.J. Pittman. 1997. Ibogaine and a total alkaloid extract of Voacanga africana modulate neuronal excitability and synaptic transmission in the rat parabrachial nucleus in vitro. Brain Res. Bul. 44:603–610.
Kubo, I. and I. Kinst-Hori. 1999. 2-hydroxy-4-methoxybenzaldehyde: A potent tyrosinase inhibitor from African medicinal plants. Planta Med. 65:19–22.
Luo, J., D.M. Fort, T.J. Carlson, B.K. Noamesi, D. nii-Amon-Kotei, S.R. King, J. Tsai, J. Quan, C. Hobensack, P. Lapresca, N. Waldeck, C.D. Mendez, S.D. Jolad, D.E. Bierer, and G.M. Reaven. 1998. Cryptolepis sanguinolenta: An ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent. Diabetic Med. 15:367–374.
Marnewick, J., E. Joubert, S. Joseph, S. Swanevelder, P. Swart, and W. Gelderblom. 2005. Inhibition of tumour promotion in mouse skin by extracts of rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), unique South African herbal teas. Cancer Lett. 224:193–202.
Marnewick, J.L., W.C.A. Gelderblom, and E. Joubert. 2000. An investigation on the antimutagenic properties of South African herbal teas. Mutation Res.-Genet. Toxicol. Environ. Mutagenesis 471:157–166.
Merck. 1989. The Merck Index 11th ed. Merck, Rahway, NJ.
Neuwinger, H.D. 2000. African traditional medicine. A dictionary of plant use and applications. Medpharm Scientific Publ. Germany.
Nihei, K., Y. Yamagiwa, T. Kamikawa, and I. Kubo. 2004. 2-Hydroxy-4-isopropylbenzaldehyde, a potent partial tyrosinase inhibitor. Bioorganic Med. Chem. Lett. 14:681–683.
Oliver-Bever, B. 1986. Medicinal plants of tropical West Africa. Cambridge Univ. Press, London. p. 375.
Palmer, E. and N. Pitman. 1972. Trees of Southern Africa. Balkema, Cape Town.
Patnam, R., S.S. Kadali, K.H. Koumaglo, and R. Roy. 2005. A chlorinated coumarinolignan from the African medicinal plant, Mondia whitei. Phytochemistry 66:683–686.
Paulo, A., A. Duarte, and E.T. Gomes. 1994b. In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids. J. Ethnopharmacol. 44:127–130.
Paulo, A., E.T. Gomes, J. Steele, D.C. Warhurst, and P.J. Houghton. 2000. Antiplasmodial activity of Cryptolepis sanguinolenta alkaloids from leaves and roots. Planta Med. 66:30–34.
Paulo, A. and P.J. Houghton. 2003. Chemotaxonomic analysis of the genus Cryptolepis. Biochem. Syst. Ecol. 31:155–166.
Paulo, A., M. Pimentel, S. Viegas, I. Pires, A. Duarte, J. Cabrita, and E.T. Gomes. 1994a. Cryptolepis sanguinolenta activity against diarrhoeal bacteria. J. Ethnopharmacol. 44:73–77.
Poukens-Renwart, P., M. Tits, and L. Angenot. 1996. Quantitative densitometric evaluation of harpagoside in the secondary roots of Harpagophytum procumbens. DC. J. Planar Chromatography 9:199–202.
Rolland, Y., N. Kunesch, J. Poisson, E.W. Hagaman, F.M. Schell, and E. Wenkert. 1976. Voacanga alkaloids. 16. Carbon-13 nuclear magnetic resonance spectroscopy of naturally occurring substances. 43. Carbon-13 nuclear magnetic resonance analysis of bis-indoline alkaloids of two voacanga species. J. Org. Chem. 41:3270–3275.
Sawer I.K., M.I. Berry, and J.L. Ford. 2005. The killing effect of cryptolepine on Staphylococcus aureus. Lett. Appl. Microbiol. 40:24–29.
331
Botanicals and Medicinals
Shatkina, L., R. Shatkina, and S. Gurevich. 2006. Meal replacement products having appetite suppressing qualities. U.S. Pat. 2006083795
Silva, O., A. Duarte, J. Cabrita, M. Pimentel, A. Diniz, and E. Gomes. 1996. Antimicrobial activity of Guinea-Bissau traditional remedies. J. Ethnopharmacol. 50:55–59.
Standley, L., P. Winterton, J.L. Marnewick, W.C.A. Gelderblom, E. Joubert, and T.J. Britz. 2001. Influence of processing stages on antimutagenic and antioxidant potentials of rooibos tea. J. Agr. Food Chem. 49:114–117.
Tackie, A.N., B.D. Dwuma, J.S.K. Ayim, T.T. Dabra, J.E. Knapp, D.J. Slatkin, and P.L. Schiff, Jr. 1975. Hydroxyphenylalkanones from Aframomum melegueta. Phytochemistry 14:853–854.
Tan, P.V., C.K. Njimi, and J.F. Ayafor. 1997. Screening of some African medicinal plants for antiulcerogenic activity. 1. Phytother. Res. 11:45–47.
Tan, P.V., V.B. Penlap, B. Nyasse, and J.D.B. Nguemo. 2000. Anti-ulcer actions of the bark methanol extract of Voacanga africana in different experimental ulcer models in rats. J. Ethnopharmacol. 73:423–428.
Tona, L., K. Kambu, N. Ngimbi, K. Cimanga, and A.J. Vlietinck. 1998. Antiamoebic and phytochemical screening of some Congolese medicinal plants. J. Ethnopharmacol. 61:57–65.
Tona, L., N.P. Ngimbi, M. Tsakala, K. Mesia, K. Cimanga, S. Apers, T. De Bruyne, L. Pieters, J. Totte, and A.J. Vlietinck. 1999. Antimalarial activity of 20 crude extracts from nine African medicinal plants used in Kinshasa, Congo. J. Ethnopharmacol. 68:193–203.
Ulicna, O., M. Greksak, O. Vancova, L. Zlatos, S. Galbavy, P. Bozek, and M. Nakano. 2003. Hepatoprotective effect of rooibos tea (Aspalathus linearis) on CCl4-induced liver damage in rats. Physiol. Res. 52:461–466.
Van Heerden, F.R., B.E. van Wyk, A.M. Viljoen, and P.A. Steenkamp. 2003. Phenolic variation in wild populations of Aspalathus linearis (rooibos tea). Biochem. Syst. Ecol. 31:885–895.
Van Wyk, B. and N. Gericke. 2000. People’s plants. A guide to useful plants of Southern Africa. Briza Publ., Pretoria, South Africa.
Van Wyk, B.E., B. van Oudtshoorn, and N. Gericke. 1997. Medicinal plants of South Africa. Briza Publ., Pretoria, South Africa.
VonGadow, A., E. Joubert, and C.F. Hansmann. 1997. Comparison of the antioxidant activity of aspalathin with that of other plant phenols of rooibos tea (Aspalathus linearis), alpha-tocopherol, BHT, and BHA. J. Agr. Food Chem. 45:632–638.
Watcho, P., M.M. Donfack, F. Zelefack, T.B. Nguelefack, S. Wansi, F. Ngoula, P. Kamtchouing, E. Tsamo, and A. Kamanyi. 2005. Effects of the hexane extract of Mondia whitei on the reproductive organs of male rat. Afr. J. Trad. Complementary Alternative Med. 2(3):302–311.
Watcho, P., P. Kamtchouing, S. Sokeng, P.F. Moundipa, J. Tantchou, J.L. Essame, and N. Koueta. 2001. Reversible antispermatogenic and antifertility activities of Mondia whitei L. in male albino rat. Phytother. Res. 15:26–29.
Watcho, P., D. Fotsing, F. Zelefack, T.B. Nguelefack, P. Kamtchouing, E. Tsamo, and A. Kamanyi. 2006. Effects of Mondia whitei extracts on the contractile responses of isolated rat vas deferens to potassium chloride and adrenaline. Indian J. Pharmacol. 38:33–7.
Watcho, P., P. Kamtchouing, S.D. Sokeng, P.F. Moundipa, J. Tantchou, J.L. Essame, and N. Koueta. 2004. Androgenic effect of Mondia whitei roots in male rats. Asian J. Androl. 6:269–272.
Willcox, M.L. and G. Bodeker. 2004. Traditional herbal medicines for malaria. BMJ 329:1156–1159
Williamson E. and F.J. Evans. 1988. Potter’s new encyclopedia of botanical drugs and preparations. C.W. Saffron, Walden, England.
Wilson, N.L.W. 2005. Cape natural tea products and the US market: Rooibos rebels ready to raid. Rev. Agr. Econ. 27:139–148.
Wright, C.W., J. Addae-Kyereme, A.G. Breen, J.E. Brown, M.F. Cox, S.L. Croft, Y. Gokcek, H. Kendrick, R.M. Phillips, and P.L. Pollet. 2001. Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. J. Med. Chem. 44:3187–3194.
Wright, C.W. 2005. Traditional antimalarials and the development of novel antimalarial drugs. J. 

https://www.hort.purdue.edu/newcrop/ncnu07/pdfs/simon322-331.pdf

Ethnopharmacol. 100:67–71.

Traditional healing

Traditional healing

Medicinal trees

Medicinal trees

grain.org - english

Biodiversity Policy & Practice - Daily RSS Feed

Rainforest Portal RSS News Feed

What's New on the Biosafety Protocol

Rainforest Portal RSS News Feed